Beta-Lactam Antibiotics for Clinical Use

Stephen Queener, Sherry Queener
Taylor & Francis, 29 mei 1986 - 680 pagina's
0 Recensies
Presenting authoritative reviews of the sources of beta-lactam antibiotics, their mechanisms of action, manufacture, clinical utility, and pharmacology, this important volume gathers together the work of 33 distinguished experts to provide the most complete coverage of these drugs available in a single source. Beta-Lactam Antibiotics for Clinical Use organizes information from microbiology, fermentation science, organic chemistry, clinical medicine, pharmacokinetics, and pharmacodynamics in a unified, interdisciplinary approach ... focuses on the beta-lactams that are, or will shortly be, clinically significant ... identifies both present and projected markets for each antibiotic ... and examines general manufacturing methods for preparing each antibiotic, including the fermentation of intermediates. Containing over 2,300 bibliographic citations of the literature and numerous tables, drawings, and photographs, this book comprises a unique reference for microbiologists and cell biologists; pharmacologists; R&D personnel and research supervisors in the pharmaceutical industry; chemotherapists; toxicologists; industrial and medicinal chemists and biochemists; graduate students in microbiology and pharmacology; and continuing education and staff training programs in microbiology and pharmacology. Book jacket.

Wat mensen zeggen - Een recensie schrijven

We hebben geen recensies gevonden op de gebruikelijke plaatsen.

Over de auteur (1986)

Queener is Professor of Pharmacology and Toxicology at Indiana University School of Medicine in Indianapolis, where she has taught since 1971. Dr. Quenner received the Ph.D. degree in biochemistry from the University of Illinois at Urbana.

Webber is Research Associate at Eli Lilly and Company Research Laboratories in Indianapolis, where he has worked since 1966. Dr. Webber received the B.A. degree in chemistry from the University of Colorado in Boulder and Ph.D. degree in organic chemistry from Stanford University.

Queener is Research Associate, Department of Antibiotic Culture Development, Biochemical Division of Eli Lilly and Company in Indianapolis, Indiana, where he has worked since 1970. Dr. Queener received the Ph.D. degree in biochemistry from the University of Illinois at Urbana.

Bibliografische gegevens